FORMYCON AG

Italy

All drugs from this manufacturer

  • AHZANTIVE

    This medicine is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema caused by retinal vein occlusion or diabetes, and myopic choroidal neovascularization.

    Dosage form: solution for injection

    Active substance Dosage
    aflibercept -

    ATC: S01LA05

  • This medicine is injected into the eye to treat several vision diseases in adults, including age-related neovascular macular degeneration, macular edema caused by retinal vein occlusion or diabetes, and myopic choroidal neovascularization.

    Dosage form: solution for injection

    Active substance Dosage
    aflibercept -

    ATC: S01LA05

  • Fymskina is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Dosage form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05